Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for ...

Achieving near-total plastic circularity is not only feasible, it is the most cost-effective and humane path forward in a ...

Bone regeneration continues to be a critical challenge in tissue engineering, with unpredictable outcomes often hindering ...

Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...

Cytora's proprietary oral mucosa stem cells treatment holds potential to be a game changer in the field of stem cell therapy ...

A Four-Season Guide to Weather and Health,” being released Tuesday, explains the science and long fascination with how the ...

Patient associations are shaping trials, asking hard questions, and demanding realistic timelines for treatment delivery.

Recent findings in bone regeneration research, highlights the significant impact of biological sex and donor variability on ...

Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future ...

Anixa Biosciences stock jumps 13% on new patent grant for its breast cancer vaccine technology in the United States.

Early-onset CRC (EO-CRC) was associated with Flavonifractor plautii and increased bile acid, tryptophan, and choline ...